SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹59 Cr | ₹20 Cr | ₹11 Cr | ₹1,184,602 Cr | ₹5.66 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹59 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹1,184,602 Cr |
Mar2020 | ₹5.66 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹59 Cr | 187.19 | |
Mar2023 | ₹20 Cr | 82.98 | |
Mar2022 | ₹11 Cr | -100.00 | |
Mar2021 | ₹1,184,602 Cr | 20,929,263.25 | |
Mar2020 | ₹5.66 Cr | - |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹540.8 Cr | -14.5% | -38.8% | 31.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | -14.5% |
-38.8% |
31.3% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses